IDP-023
Phase 1/2 Study of IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic Cancers
Near Add Your Location
Sorting 10 by
University of Minnesota - Masonic Cancer Center
Minneapolis, MN
- Accepting patients
- Accepting patients
Virginia Cancer Specialists
Fairfax, VA
- Accepting patients
Weill Cornell
New York, NY
- Accepting patients
- Show Principal Investigator
Lifespan Rhode Island Hospital
Providence, RI
- Accepting patients
- Accepting patients
- Accepting patients
- Accepting patients
- Accepting patients
Valkyrie Clinical Trials
Los Angeles, CA
- Accepting patients
Showing 1-10 of 10
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.